Description

PT-141 – ADVANCED SEXUAL WELLNESS & LIBIDO SUPPORT

Elevate Wellness Hub’s PT-141 (bremelanotide) is a melanocortin receptor agonist that acts on pathways involved in sexual desire and arousal. Bremelanotide is a prescription medicine approved in the United States for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.

KEY BENEFITS

• Supports sexual desire in eligible patients

• Supports research into sexual arousal pathways

• Acts on melanocortin receptor signalling

• May help address clinically diagnosed HSDD in appropriate patients

• Supports research into neurobiological pathways involved in sexual motivation

WHO MAY BENEFIT?

Bremelanotide is specifically indicated for premenopausal women with acquired, generalized HSDD when the condition causes significant distress or interpersonal difficulty and is not attributable to another medical or psychiatric condition, relationship problems, or medication or drug effects.

It is not indicated for postmenopausal women, men, or enhancement of sexual performance.

Always use under the guidance of a qualified healthcare professional.

HOW IT MAY HELP

• PT-141 activates melanocortin receptors in the central nervous system

• Its mechanism is different from medications that directly increase genital blood flow

• Clinical studies have demonstrated improvements in sexual desire and reductions in distress associated with HSDD in appropriately selected premenopausal women

• Its effects are related primarily to central nervous-system pathways involved in sexual desire and motivation

POSSIBLE SIDE EFFECTS

Common adverse effects may include:

• Nausea

• Flushing or hot flushes

• Headache

• Vomiting

• Injection-site reactions

• Dizziness

• Fatigue

• Temporary increase in blood pressure

• Temporary decrease in heart rate

• Focal hyperpigmentation

Nausea is particularly common with bremelanotide and can be significant in some patients.

NOT SUITABLE FOR

• Pregnancy

• Individuals with uncontrolled hypertension

• Individuals with known cardiovascular disease

• Anyone with a known serious allergy or hypersensitivity to bremelanotide or its ingredients

• Postmenopausal women when seeking treatment for HSDD

• Men seeking treatment for sexual dysfunction

• Anyone seeking general sexual-performance enhancement

Bremelanotide is contraindicated in patients with uncontrolled hypertension or known cardiovascular disease.

IMPORTANT DISCLAIMER

PT-141 (bremelanotide) is a prescription medicine with a specific approved indication. It should not be marketed as a general libido booster or as a treatment for all forms of sexual dysfunction.

Bremelanotide can temporarily increase blood pressure and decrease heart rate. It may also cause significant nausea and can interact with certain medications, including orally administered naltrexone products. Appropriate medical assessment is therefore required before use.

Elevate Wellness Hub does not represent PT-141 as a substitute for appropriate medical care. Use should comply with applicable laws, prescribing requirements, and qualified healthcare-professional supervision.

The 10 mg listed by Elevate Wellness Hub refers to the product strength and is not a dosing recommendation.

It’s not just about feeling better, it’s about elevating your quality of life.

ELEVATE WELLNESS HUB – PEPTIDE WELLNESS. SCIENCE BACKED. RESULTS DRIVEN. YOU ELEVATED.